医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Sanchaeman Launches Ready Meals Brand ‘Bibyeoyo’ for Korean Traditional Gondeure-Bap

2019年07月24日 PM09:00
このエントリーをはてなブックマークに追加


 

INJE, GANGWON-DO, South Korea

A traditional Korean food Gondeure-bap, which is the rice cooked with Korean thistle (Gondeure), is now available worldwide.

Sanchaeman Co., Ltd., a Korean food supplier that provides fresh foods made of farm products from Gangwon-do, has launched the Bibyeoyo, a pre-cooked Gondeure with which consumers make Gondeure-bap quick and easy.

Sanchaeman’s Bibyeoyo only uses blanched Gondeure from Gangwon-do without any chemical additives and contains fermented raw bellflower essence to add a deep flavor. Consumers just can pour the contents over a bowl of rice and mix well to make a delicious meal full of nutrition. It’s also a perfect fit for vegetarians.

Korean thistle, also known as Goryeo thistle, is a type of wild edible greens that has a unique light, smooth and aromatic flavor. It contains a variety of vitamins and beta carotene. It also boasts rich fiber content and low-calories.

When eaten blanched, steamed, or seasoned, the gondeure helps bowel movements to relieve constipation and improve skin health.

“Bibyeoyo is nutritious and convenient to eat. It’s the best food for busy modern people,” said Sang-mi Park, a president of Sanchaeman.

Sanchaeman’s Bibyeoyo has four types of flavor: earthy, a little spicy, Sanchaebibim, and Gangdoenjang.

It can be purchased from Kangwonmall, Gangwon-do’s specialty foods website: http://chan24.co.kr

View source version on businesswire.com: https://www.businesswire.com/news/home/20190724005039/en/

CONTACT

Sanchaeman Co., Ltd.

Sang-mi Park

+82-33-461-1062

tkdal7877@hanmail.net

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease